Sex Differences in Alzheimer’s Disease: Risk Factors and Biomarkers
EMJ Podcast: Insights For Healthcare Professionals
Release Date: 06/01/2026
Where Oncology Meets Public Policy: Translating Innovation into Policy
EMJ Podcast: Insights For Healthcare Professionals
How does scientific evidence become public policy? In the final episode, Christopher Cogle discusses the challenges of translating healthcare innovation into large-scale policy change. Topics include housing policy and mortality, youth tobacco use, vaping regulation, and how the COVID-19 pandemic reshaped public health decision-making. Timestamps: 00:49 – Public Startup 07:08 - Challenges 15:01 – Housing policy 16:28 – Tobacco policy 19:05 – COVID-19
info_outline
Where Oncology Meets Public Policy: Quality of Life of Cancer Survivors
EMJ Podcast: Insights For Healthcare Professionals
In Part 2, Christopher Cogle examines the long-term realities facing cancer survivors. From vaccine hesitancy and quality-of-life disparities to healthcare access and survivorship policy, this episode explores how systems can better support patients beyond active treatment. Timestamps: 00:50 – Vaccine hesitancy 04:33 – QoL after cancer 07:30 – Policy support 11:10 – Survivorship care
info_outline
Where Oncology Meets Public Policy: Innovations in Acute Myeloid Leukaemia
EMJ Podcast: Insights For Healthcare Professionals
In this first deep dive, Christopher Cogle explores the evolving landscape of acute myeloid leukaemia (AML). He discusses the challenge of translating research into real-world outcomes, emerging immunotherapies, precision diagnostics, and how innovations such as the Acute Leukemia Methylome Atlas may reshape AML management in the future. Timestamps: 00:55 – Research Gaps 03:50 – Biologics 05:46 – AML Atlas 09:15 – Immunotherapy
info_outline
Quickfire: Where Oncology Meets Public Policy
EMJ Podcast: Insights For Healthcare Professionals
Christopher Cogle joins the EMJ Podcast for a quickfire discussion on oncology, innovation, and public health policy. From personalised cancer care and AI in medicine to AML challenges and healthcare reform, he shares concise insights from across clinical medicine and policy leadership.
info_outline
Women’s Heart Health: Equity, Bias, and the Future of Cardiovascular Care
EMJ Podcast: Insights For Healthcare Professionals
In the final episode, Sharonne N. Hayes discusses how structural inequities and unconscious bias continue to affect cardiovascular outcomes for women and minority patients. From improving diversity in research to leveraging social media responsibly, this episode explores what the future of equitable cardiovascular care could look like. Timestamps: 0:58 – Health equity 4:02 – Improving representation 7:10 – Role of social media 9:54 – 10-year prediction 11:08 – Sharonne's wish
info_outline
Women’s Heart Health: Rethinking Heart Attack in Women
EMJ Podcast: Insights For Healthcare Professionals
In Part 2, Sharonne N. Hayes explores spontaneous coronary artery dissection (SCAD) and how it challenges traditional assumptions about heart attacks. Learn how SCAD differs from atherosclerotic disease, what recent research has uncovered, and how clinicians can navigate complex management decisions. Timestamps: 1:06 – What is SCAD? 2:47 – Practice-changing insights 6:35 – Hormonal influences 8:20 – Therapeutic ambiguity
info_outline
Onc Now: The Next Decade of Hepatobiliary and Pancreatic Cancer Care
EMJ Podcast: Insights For Healthcare Professionals
In this episode of Onc Now, Stephen Chan, Clinical Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong, explores the evolving landscape of hepatobiliary and pancreatic cancers. From advances in translational science and precision therapies to the challenges of neuroendocrine tumour care, Chan reflects on the progress made in oncology and the breakthroughs still needed. He also discusses his work with the Hand-in-Hand Cancer Foundation, highlighting the importance of education, compassion, and holistic support for patients and their families. ...
info_outline
AMJ Podcast | Episode 8 | Real-World Insights into Biologic Initiation and Adherence in Severe Asthma Inside
EMJ Podcast: Insights For Healthcare Professionals
This podcast was developed by AMJ in collaboration with GSK and is sponsored by GSK. This information is scientific and non-promotional in nature, and intended for US audiences. Less than 20% of biologic-eligible patients with GINA Step 5 asthma receive biologic therapy.1,2 In this AMJ podcast, experts discuss how real-world gaps in initiation, access, and adherence can affect whether patients start, stay on, and sustain benefit from biologic therapy over time. Listen to the full episode to explore: Key real-world data on biologic initiation and adherence in severe asthma...
info_outline
Women’s Heart Health: Understanding Sex-Specific Cardiovascular Risk
EMJ Podcast: Insights For Healthcare Professionals
Sharonne N. Hayes joins host Saranya Ravindran to discuss how cardiovascular disease presents differently in women. From pregnancy-related complications and menopause to microvascular disease and gaps in clinician education, this episode explores the importance of sex-specific cardiovascular care. Timestamps: 1:04 – Sex-specific differences 2:43 – Pregnancy and preeclampsia 4:38 – Historic underdiagnosis 7:00 – Menopause and hormones 10:04 – Education and training
info_outline
Quickfire: Women’s Heart Health
EMJ Podcast: Insights For Healthcare Professionals
In this rapid-fire episode, Sharonne N. Hayes answers key questions on women’s cardiovascular health, SCAD, unconscious bias, prevention, and the future of equitable heart care. A concise, expert-led overview of the field.
info_outlineIn this first deep dive, Rachel Buckley joins host Catherine Glass to explore how Alzheimer’s disease risk can be detected before symptoms appear. From blood-based biomarkers like p-tau217, to AI-driven models of cognitive resilience, the episode examines how risk, progression, and protection can be better understood and predicted over time.
Timestamps:
00:00:57:11 – Phosphorylated tau and amyloid-PET
00:08:15:05 – Biomarkers, risk, and progression
00:11:18:04 – Brain resistance and cognitive resilience
00:15:23:23 – AI biases